Additional results are presented in the supplementary material (in Supplementary Material available online at http://dx.doi.org/10.1155/2015/276815): distribution of ESR and CRP by gender and age (Supplementary Table 1) and frequencies of anti-CCP and rheumatoid factor (Supplementary Table 2); the clinical assessment of the RA patients (SWJ28, TEN28, ESR, CRP, MDGA-VAS, and PGA-VAS) during the study (Supplementary Figure 1); and the RA patients grouped by disease activity (Supplementary Figure 2) and the serum IgG-RF and anti-CCP titers during the study (Supplementary Figure 3). This evidence concerns the gene CRP and rheumatoid arthritis.